Josh Brown, CEO of Ritholtz Wealth Management, explained in a recent program on CNBC why he’s bearish on Pfizer. Brown said he was “dead wrong” in hoping to see a turnaround at the pharma ...

On July 24, 2025, Pfizer Inc. (NYSE:PFE) finalized the global licensing agreement with 3SBio, Inc. With this agreement, PFE acquired the exclusive rights to develop, manufacture, and commercialize ...

On July 24, 2025, Pfizer Inc. (NYSE:PFE) finalized the global licensing agreement with 3SBio, Inc. With this agreement, PFE acquired the exclusive rights to develop, manufacture, and commercialize ...

Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Au lendemain de la Seconde Guerre mondiale, un élan démocratique se fait jour en Amérique latine. Il s’exprime au travers d’élections (Argentine, Chili, Costa Rica, Pérou, Uruguay), mais se manifeste ...

Des experts de l'Université Pomeranian Medical à Szczecin, de l'Institut de la mémoire nationale et de la Fondation des Antiquités de Volhynie (Wołyńskie starożytności) ont participé aux travaux ...

Pfizer (PFE) closed at $25.62 in the latest trading session, marking a +1.51% move from the prior day.

Le point-virgule signale une nouvelle étape franchie, par exemple après une thérapie réussie, choix prisé chez les alcooliques ou les narcotiques anonymes. Rite, sens, mémoire ...

Honorer la mémoire des victimes 12 ans après la tragédie ferroviaire de Lac-Mégantic Les Méganticois rendent hommage aux victimes de la tragédie ferroviaire 12 ans plus tard.

Discover why options trading trends, robust R&D, and strong free cash flow position Pfizer Inc. for growth. Click for my updated look at PFE stock prospects.

PFIZER INC (PFE) is a large-cap growth stock in the Biotechnology & Drugs industry. The rating using this strategy is 95% based on the firm’s underlying fundamentals and the stock’s valuation.